Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in

BARD1 Life Sciences Ltd
ASX:BD1

Watchlist Manager
BARD1 Life Sciences Ltd Logo
BARD1 Life Sciences Ltd
ASX:BD1
Watchlist
Price: 1.04 AUD Market Closed
Market Cap: AU$83.3m
Write Note Create Alert Ask AI

BARD1 Life Sciences Ltd
Investor Relations

BARD1 Life Sciences Ltd. is a biotechnology company, which engages in the provision of medical services. The firm is engaged in research, development, and commercialization of non-invasive diagnostic products for the early detection of cancer. The Company’s technologies include BARD1, SubB2, NET and hTERT. BARD1 is a biomarker platform covering various tumor markers including nucleic acids, proteins, and autoantibodies for early cancer diagnosis.SubB2M is a pan-cancer probe for monitoring cancer treatment response and recurrence across a wide range of cancers. NET is designed to capture and purify biomarkers, including acids, cells, and exosomes. hTERT is an antibody-based assay to detect hTERT, a component of telomerase, in cells.

Show more
Loading
BD1
S&P/ASX 300
1Y 3Y 5Y 10Y 15Y 20Y
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Dr. Leearne Maree Hinch B.Sc., B.V.M.S., BSc., M.B.A., M.R.C.V.S.
Chief Exec. Officer
No Bio Available
Mr. Tony Di Pietro AGIA, B.Com, C.A., CPA, M.A.I.C.D.
CFO & Company Sec.
No Bio Available
Mr. Peter Lynton Gunzburg ASIA, B Comm, B.Com.
Managing Director
No Bio Available
Prof. Gregory Edward Rice BSc (Hons), GradDipMgt, MHA, Ph.D.
Chief Scientific Officer
No Bio Available

Contacts

Address
VICTORIA
23 Normanby Road, Notting Hill
Contacts
+61395487586
www.bard1.com
sparklesyt

See Also

Summary
BD1 intrinsic value, competitors valuation, and company profile.
DCF Valuation
BD1 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BD1 stock valuation using valuation multiples.
Wall Street Estimates
BD1 price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BD1 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 315,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.